FDA Panel Votes For Tougher Controls On Hydrocodone

Law360, New York (January 25, 2013, 5:36 PM EST) -- A U.S. Food and Drug Administration advisory committee on Friday recommended putting more restrictions on hydrocodone combination painkillers, some of the most prescribed and abused drugs in the country, a move opposed by the generic pharmaceutical industry as well as pharmacies.

The committee voted 19 to 10 to move hydrocodone combo drugs, such as Vicodin, from Schedule III of the Controlled Substances Act into Schedule II. Schedule II drugs, which are considered to have a high potential for abuse, require a written prescription, cannot be refilled...
To view the full article, register now.